本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Janux Therapeutics, Inc.

17.10
-0.5800-3.28%
盤後17.340.2400+1.40%19:45 EDT
成交量:79.16萬
成交額:1,363.96萬
市值:10.45億
市盈率:-10.41
高:17.94
開:17.92
低:17.05
收:17.68
52周最高:35.34
52周最低:12.12
股本:6,113.68萬
流通股本:4,252.58萬
量比:0.79
換手率:1.86%
股息:- -
股息率:- -
每股收益(TTM):-1.6429
每股收益(LYR):-1.8336
淨資產收益率:-10.70%
總資產收益率:-8.80%
市淨率:1.13
市盈率(LYR):-9.33

資料載入中...

2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/05

重要事件披露

Form 8-K - Current report
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/05

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities